In addition to this phenomenon found in depression, in Parkinson’s disease, we have found that neurotrophins are specific to the promotion of neurogenesis in the brain and could have potential in the treatment of Parkinson’s disease as a complement to cellular replacement therapies [112]. This evidence concerns the gene BDNF and depressive symptom measurement.